FDA Approves Hep C Drugs for Kids 12 and Older

FRIDAY, April 7, 2017 — The U.S. Food and Drug Administration has approved two drugs to treat hepatitis C infection in children aged 12 and older.
Both Solvaldi (sofosbuvir) and Harvoni (ledipasvir, sofosbuvir) are already approved for use in…
Source: Topamax